Get Clarity, Not Just Headlines.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Leo XIV
Pope Francis
Mother's Day
Vatican
Artificial Intelligence
Catholic Church
Parade
Social Media
World War II
European Union
Stock Markets
Vladimir Putin
Published • loading... • Updated

Evolocumab May Shift Plaque Profile Toward Lower Cardiovascular Risk

Summary by hcplive.com
Evolocumab reshapes arterial plaque, reducing cardiovascular risk by lowering microcalcification and shifting plaque composition over 18 months.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
hcplive.comhcplive.com

Evolocumab May Shift Plaque Profile Toward Lower Cardiovascular Risk

Evolocumab reshapes arterial plaque, reducing cardiovascular risk by lowering microcalcification and shifting plaque composition over 18 months.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

hcplive.com broke the news in on Thursday, May 8, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal